Common Variable Immunodeficiency
33
5
8
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.1%
2 terminated out of 33 trials
90.9%
+4.4% vs benchmark
30%
10 trials in Phase 3/4
40%
8 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (33)
Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Natural History of Bronchiectasis
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France
Peripheral Helper T-cells in Common Variable ImmunoDeficiency
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
COVID-19 Vaccine Responses in PIDD Subjects
Lymphocyte Immunophenotyping in Common Variable Immunodeficiency
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Common Immunodeficiency
Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide
Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease
Human IgGs and Endothelial Function in Vivo in Humans